Bayobay, Baby Girl .

HRN: 27-01-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
AMPICILLIN 250MG (VIAL)
04/26/2025
05/02/2025
IV
200 Mg
Q12H
PSNB
Waiting Final Action 
04/26/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/26/2025
05/02/2025
IV
55 Mg
Q24H
PSNB
Waiting Final Action 
03/01/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/01/2026
03/08/2026
IVTT
285mg
Q6h
PCAP-C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: